Two Sigma Securities’s Acer Therapeutics Inc ACER Stock Holding History

Two Sigma Securities’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-26,533	Closed	-$21.6K	–	3793
2023 Q3	$21.6K	Buy	26,533 +1,923	+8%	+$1.58K	﹤0.01%	2560
2023 Q2	$22.7K	Buy	+24,610	New	+$21.8K	﹤0.01%	2489
2023 Q1	–	Sell	-19,747	Closed	-$49.6K	–	3456
2022 Q4	$49.6K	Buy	+19,747	New	+$33.9K	﹤0.01%	2164
2022 Q1	–	Sell	-12,576	Closed	-$29K	–	2641
2021 Q4	$29K	Buy	+12,576	New	+$29.2K	﹤0.01%	1366
2020 Q3	–	Sell	-16,984	Closed	-$58K	–	1727
2020 Q2	$58K	Buy	+16,984	New	+$47.9K	﹤0.01%	1248
2017 Q3	–	Sell	-2,758	Closed	-$19K	–	1284
2017 Q2	$19K	Buy	+2,758	New	+$18.3K	﹤0.01%	786
2017 Q1	–	Sell	-1,103	Closed	-$11K	–	1167
2016 Q4	$11K	Buy	+1,103	New	+$19.3K	﹤0.01%	672

Other funds holding ACER

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Two Sigma Securities's ACER Position: Q4 2023 in Review

Two Sigma Securities sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 26,533 shares — an estimated $21.6K sold.

Two Sigma Securities first reported a position in ACER in Q4 2016 and held it in 7 quarters. The position peaked at $58K in Q2 2020. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.

Two Sigma Securities reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
Two Sigma Securities sold 26,533 Acer Therapeutics Inc shares in Q4 2023, an estimated $21.6K.
Two Sigma Securities first reported a position in Acer Therapeutics Inc in Q4 2016 and held it in 7 quarters.
Two Sigma Securities's Acer Therapeutics Inc position peaked at $58K in Q2 2020.
2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.